Jacqueline Elizabeth Shea
Chief Executive Officer at Inovio Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Inovio Pharmaceuticals Inc., 3 years.
Inovio Pharmaceuticals Inc.
Director · Chief Executive Officer
Chief executive roles
Inovio Pharmaceuticals Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 20, 2026 | Inovio Pharmaceuticals Inc. | Option exercise | +28,296 | — | — |
| May 20, 2026 | Inovio Pharmaceuticals Inc. | Shares withheld for tax | −12,306 | $1.23 | $15,136 |
| May 15, 2026 | Inovio Pharmaceuticals Inc. | Option exercise | +17,744 | — | — |
| May 15, 2026 | Inovio Pharmaceuticals Inc. | Shares withheld for tax | −7,717 | $1.30 | $10,032 |
| Feb 26, 2026 | Inovio Pharmaceuticals Inc. | Option exercise | +18,632 | — | — |
| Feb 26, 2026 | Inovio Pharmaceuticals Inc. | Shares withheld for tax | −8,057 | $1.79 | $14,422 |
| Feb 26, 2026 | Inovio Pharmaceuticals Inc. | Option exercise | +28,401 | — | — |
| Feb 26, 2026 | Inovio Pharmaceuticals Inc. | Shares withheld for tax | −13,657 | $1.79 | $24,446 |
| May 15, 2025 | Inovio Pharmaceuticals Inc. | Option exercise | +17,744 | — | — |
| May 15, 2025 | Inovio Pharmaceuticals Inc. | Shares withheld for tax | −7,717 | $1.95 | $15,048 |
| May 10, 2025 | Inovio Pharmaceuticals Inc. | Option exercise | +5,500 | — | — |
| May 10, 2025 | Inovio Pharmaceuticals Inc. | Shares withheld for tax | −2,392 | $1.80 | $4,306 |
| Feb 26, 2025 | Inovio Pharmaceuticals Inc. | Option exercise | +5,852 | — | — |
| Feb 26, 2025 | Inovio Pharmaceuticals Inc. | Shares withheld for tax | −2,493 | $1.98 | $4,936 |
| Feb 26, 2025 | Inovio Pharmaceuticals Inc. | Option exercise | +18,632 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.